These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32750166)

  • 1. A Novel Presentation of the Acute Airway: Anti-IgLON5 Disease.
    Chen J; Vasani S
    Laryngoscope; 2021 Mar; 131(3):E724-E726. PubMed ID: 32750166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the Clinical Spectrum of IgLON5-Syndrome.
    Wenninger S
    J Neuromuscul Dis; 2017; 4(4):337-339. PubMed ID: 29103046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease.
    Gaig C; Ercilla G; Daura X; Ezquerra M; Fernández-Santiago R; Palou E; Sabater L; Höftberger R; Heidbreder A; Högl B; Iranzo A; Santamaria J; Dalmau J; Graus F
    Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31454761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations of the anti-IgLON5 disease.
    Gaig C; Graus F; Compta Y; Högl B; Bataller L; Brüggemann N; Giordana C; Heidbreder A; Kotschet K; Lewerenz J; Macher S; Martí MJ; Montojo T; Pérez-Pérez J; Puertas I; Seitz C; Simabukuro M; Téllez N; Wandinger KP; Iranzo A; Ercilla G; Sabater L; Santamaría J; Dalmau J
    Neurology; 2017 May; 88(18):1736-1743. PubMed ID: 28381508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep disorders in autoimmune encephalitis.
    Muñoz-Lopetegi A; Graus F; Dalmau J; Santamaria J
    Lancet Neurol; 2020 Dec; 19(12):1010-1022. PubMed ID: 33212053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper airway manifestations of anti-IgLON5 disease: Otorhinolaryngological point of view.
    Pastene D; Lehrer E; Jubes S; Santamaria J; Iranzo A; Gaig C; Vilaseca I
    Acta Otorrinolaringol Esp (Engl Ed); 2024; 75(5):288-295. PubMed ID: 38729239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease.
    Gaig C; Compta Y
    Curr Opin Neurol; 2019 Jun; 32(3):493-499. PubMed ID: 30694925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report.
    Wang Y; Wu X; Lu B
    BMC Neurol; 2021 Mar; 21(1):120. PubMed ID: 33731000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with Serum-Restricted Antibodies: A Case Report and Systematic Review of Literature.
    Tagliapietra M; Frasson E; Cardellini D; Mariotto S; Ferrari S; Zanusso G; Plebani M; Monaco S
    J Alzheimers Dis; 2021; 79(2):683-691. PubMed ID: 33337376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Motor Abnormalities in Anti-IgLON5 Disease.
    Macher S; Milenkovic I; Zrzavy T; Höftberger R; Seidel S; Berger-Sieczkowski E; Berger T; Rommer PS; Wiest G
    Front Immunol; 2021; 12():753856. PubMed ID: 34659261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IgLON5 disease with distinctive brain MRI findings responding to immunotherapy: A case report.
    Pi Y; Zhang LL; Li JC
    Medicine (Baltimore); 2021 Jan; 100(4):e24384. PubMed ID: 33530233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative Stridor and Acute Respiratory Failure After Parkinson Disease Deep Brain Stimulator Placement: Case Report and Review of Literature.
    Wang M; Saasouh W; Botsford T; Keebler A; Zura A; Benninger MS; Avitsian R
    World Neurosurg; 2018 Mar; 111():22-25. PubMed ID: 29229347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thinking beyond otorhinolaryngology in patients presenting with bilateral vocal cord paresis.
    Usman H; Protts F; Fathers E; Chisholm E
    J Surg Case Rep; 2023 Mar; 2023(3):rjad140. PubMed ID: 37008736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching Video NeuroImages: Anti-IgLON5 Disease: A Long-Course Presentation With a Response to Immunotherapy.
    Villacieros-Álvarez J; Ordás CM; Torres-Gaona G; Díez-Barrio A; Prieto-Jurczynska C; Gaig C
    Neurology; 2021 Jun; 96(23):e2901-e2902. PubMed ID: 33361260
    [No Abstract]   [Full Text] [Related]  

  • 15. An autopsy case of MM2-thalamic subtype of sporadic Creutzfeldt-Jakob disease with Lewy bodies presenting as a sleep disorder mimicking anti-IgLON5 disease.
    Hongo Y; Iizuka T; Kaneko A; Suga H; Uchino A; Murayama S; Namba K; Inoue Y; Nishiyama K
    J Neurol Sci; 2019 Sep; 404():36-39. PubMed ID: 31325665
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-IgLON5 Disease Showing an Improvement in Dysautonomia, Including Vocal Cord Palsy, via Combined Immunotherapy.
    Sato D; Sato H; Kondo T; Igari R; Iseki C; Kawahara H; Amano S; Ono Y; Kimura A; Shimohata T; Ohta Y
    Intern Med; 2024 Aug; 63(15):2187-2191. PubMed ID: 38171876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease: A Case Series.
    Strippel C; Heidbreder A; Schulte-Mecklenbeck A; Korn L; Warnecke T; Melzer N; Wiendl H; Pawlowski M; Gross CC; Kovac S
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35031586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the sleep disorder of anti-IgLON5 disease.
    Gaig C; Iranzo A; Cajochen C; Vilaseca I; Embid C; Dalmau J; Graus F; Santamaria J
    Sleep; 2019 Sep; 42(9):. PubMed ID: 31198936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease.
    Shambrook P; Hesters A; Marois C; Zemba D; Servan J; Gaymard B; Pico F; Delorme C; Lubetzki C; Arnulf I; Psimaras D; Honnorat J; Gales A; Méneret A
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 33986128
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-IgLON5 disease as a differential diagnosis of multiple system atrophy.
    Ono Y; Tadokoro K; Yunoki T; Yamashita T; Sato D; Sato H; Akamatsu S; Mizukami H; Ohta Y; Yamano Y; Kimura A; Shimohata T
    Parkinsonism Relat Disord; 2024 Jul; 124():106992. PubMed ID: 38701719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.